The effect of triple CFTR modulator therapy and azithromycin on ion channels and inflammation in cystic fibrosis
Background Inflammation in cystic fibrosis (CF) airways is difficult to treat with well-established regimens often including azithromycin (AZ) as an immunomodulatory drug. As AZ has been reported to require CF transmembrane conductance regulator (CFTR) to be able to reduce interleukin (IL)-8 and giv...
Saved in:
Main Authors: | Suhad Bani Melhim, Lisa E.J. Douglas, James A. Reihill, Damian G. Downey, S. Lorraine Martin |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2024-12-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/10/6/00502-2024.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A new era of cystic fibrosis therapy with CFTR modulators
by: Laura Gomes Boabaid de Barros, et al.
Published: (2025-01-01) -
Inflammation in Cystic Fibrosis
Published: (1996-01-01) -
Identification of a Mutation in the Novel Compound Heterozygous CFTR in a Chinese Family with Cystic Fibrosis
by: Hongxia Shao, et al.
Published: (2020-01-01) -
The Novel CFTR Mutation A457P in a Male with a Delayed Diagnosis of Cystic Fibrosis
by: Kate H. Cole, et al.
Published: (2011-01-01) -
New Developments in Cystic Fibrosis Airway Inflammation
by: Nades Palaniyar, et al.
Published: (2015-01-01)